BD announces acquisition of Sirigen Related StoriesBD reviews revenues of $2.

This acquisition is yet another example of our quest for growth through advancement, in this case purchasing a unique technology that allows us to differentiate our existence science study reagent portfolio and add worth for customers, stated William A. Kozy, BD Executive Vice President.. BD announces acquisition of Sirigen Related StoriesBD reviews revenues of $2.051 billion for second fiscal quarter 2015BD Lifestyle Sciences announces FDA clearance for BD MAX Enteric Parasite PanelBD reports quarterly revenues of $2.202B for Q4 2014, provides fiscal 2015 outlookBD , a respected global medical technology firm, announced today that it has acquired Sirigen Group Small, a developer of exclusive polymer dyes which are found in flow cytometry and may be employed to other systems.This study discusses existing health care structure within developing areas and the marketplace impact of key improvements. It identifies the technology roadmap and technology administration strategies and in addition covers some essential patents. Further, this research includes detailed technology evaluation and industry tendencies evaluated following intensive interviews with market individuals. Technical Insights can be an international technology evaluation business that creates a number of technical news alerts, news letters, and research services.. California unveils requirements for health plans By taking this step, California became the first condition to standardize medical health insurance plans under the federal health rules.